|
Cytokines
|
Etiology
| |
Fold activation
|
|---|
| | |
LPS
|
ODN
|
C. albicans
|
|---|
|
TNF-α
|
ALC-C
|
89.26 (204.5) a
|
0.89 (1.7)
|
170.92 (374.6) a
|
| |
HCV-C
|
97.61 (163.9) a
|
2.42 (4.9)
|
4334.96 (595.4) a
|
|
IL-6
|
ALC-C
|
2.73 (3.5) a
|
0.84 (5.8)
|
3.35 (10.4) a
|
| |
HCV-C
|
5.97 (19.6) *,a
|
1.26 (7.2)*,a
|
5.68 (37.2) *,a
|
|
IL-10
|
ALC-C
|
9.06 (6.2)a
|
0.77 (0.6)
|
13.7 (24.5) a
|
| |
HCV-C
|
11.33 (13.9) a
|
1.4 (2.6) *,a
|
223.4 (45.3) a
|
|
IL-12
|
ALC-C
|
1.75 (3.4) a
|
2.1 (8.4)
|
3.7 (6.6) a,*
|
| |
HCV-C
|
3.15 (4.8)
|
6.6 (17.4)
|
1.93 (1.1)
|
|
IL-1β
|
ALC-C
|
20.21 (63) a
|
1.5 (10)
|
46.85 (135.6) a
|
| |
HCV-C
|
10.89 (24.7) a
|
2.11 (2.73)
|
15.4 (28.5) a
|
-
Results are expressed as median (interquartile range). Mann–Whitney U test: * P < 0.05 between ALC-C and HCV-C; Wilcoxon signed-rank test:
a
P <0.05 between control and treatments.
